These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23278534)

  • 1. Aspergillus--classification and antifungal susceptibilities.
    Buzina W
    Curr Pharm Des; 2013; 19(20):3615-28. PubMed ID: 23278534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspergillus species intrinsically resistant to antifungal agents.
    Van Der Linden JW; Warris A; Verweij PE
    Med Mycol; 2011 Apr; 49 Suppl 1():S82-9. PubMed ID: 20662634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiologic study of drug-resistant Aspergillus and optimizing newer treatment].
    Izumikawa K
    Jpn J Antibiot; 2011 Feb; 64(1):27-34. PubMed ID: 21612041
    [No Abstract]   [Full Text] [Related]  

  • 4. Luliconazole, an alternative antifungal agent against Aspergillus terreus.
    Zargaran M; Taghipour S; Kiasat N; Aboualigalehdari E; Rezaei-Matehkolaei A; Zarei Mahmoudabadi A; Shamsizadeh F
    J Mycol Med; 2017 Sep; 27(3):351-356. PubMed ID: 28483449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triazole Antifungal Susceptibility Patterns among
    Cheng MP; Lawandi A; Lee TC; Dufresne PJ; Seidel D; Verweij PE; Cornely OA; Sheppard DC
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30918044
    [No Abstract]   [Full Text] [Related]  

  • 6. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive aspergillosis caused by cryptic Aspergillus species: a report of two consecutive episodes in a patient with leukaemia.
    Peláez T; Álvarez-Pérez S; Mellado E; Serrano D; Valerio M; Blanco JL; Garcia ME; Muñoz P; Cuenca-Estrella M; Bouza E
    J Med Microbiol; 2013 Mar; 62(Pt 3):474-478. PubMed ID: 23161769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of invasive aspergillosis for drug discovery.
    Paulussen C; Boulet GA; Cos P; Delputte P; Maes LJ
    Drug Discov Today; 2014 Sep; 19(9):1380-6. PubMed ID: 24931219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.
    Mello E; Posteraro B; Vella A; De Carolis E; Torelli R; D'Inzeo T; Verweij PE; Sanguinetti M
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and susceptibility of Aspergillus section nigri in china: prevalence of species and paradoxical growth in response to echinocandins.
    Li Y; Wan Z; Liu W; Li R
    J Clin Microbiol; 2015 Feb; 53(2):702-5. PubMed ID: 25502526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuances of new anti-Aspergillus antifungals.
    Perfect JR
    Med Mycol; 2005 May; 43 Suppl 1():S271-6. PubMed ID: 16110820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azole resistance in Aspergillus: a growing public health menace.
    Denning DW; Perlin DS
    Future Microbiol; 2011 Nov; 6(11):1229-32. PubMed ID: 22082283
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of drug-resistant Aspergillus infection.
    Aigner M; Lass-Flörl C
    Expert Opin Pharmacother; 2015; 16(15):2267-70. PubMed ID: 26328502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility testing in Aspergillus species complex.
    Lass-Flörl C
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():49-53. PubMed ID: 24372722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
    Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
    Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea.
    Won EJ; Shin JH; Kim SH; Choi MJ; Byun SA; Kim MN; Lee WG; Lee K; Uh Y; Shin MG; Suh SP
    Med Mycol; 2018 Jun; 56(4):501-505. PubMed ID: 28992138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
    Mosquera J; Sharp A; Moore CB; Warn PA; Denning DW
    J Antimicrob Chemother; 2002 Aug; 50(2):189-94. PubMed ID: 12161398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study.
    Risslegger B; Zoran T; Lackner M; Aigner M; Sánchez-Reus F; Rezusta A; Chowdhary A; Taj-Aldeen SJ; Arendrup MC; Oliveri S; Kontoyiannis DP; Alastruey-Izquierdo A; Lagrou K; Lo Cascio G; Meis JF; Buzina W; Farina C; Drogari-Apiranthitou M; Grancini A; Tortorano AM; Willinger B; Hamprecht A; Johnson E; Klingspor L; Arsic-Arsenijevic V; Cornely OA; Meletiadis J; Prammer W; Tullio V; Vehreschild JJ; Trovato L; Lewis RE; Segal E; Rath PM; Hamal P; Rodriguez-Iglesias M; Roilides E; Arikan-Akdagli S; Chakrabarti A; Colombo AL; Fernández MS; Martin-Gomez MT; Badali H; Petrikkos G; Klimko N; Heimann SM; Houbraken J; Uzun O; Edlinger M; Fuente S; Lass-Flörl C
    Clin Microbiol Infect; 2017 Oct; 23(10):776.e1-776.e5. PubMed ID: 28412383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on antifungal resistance in Aspergillus and Candida.
    Arendrup MC
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():42-8. PubMed ID: 24372701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.